JRJan Rottenberg

Jan Rottenberg

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jan Rottenberg has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Bretislav Gal

    Department of Otorhinolaryngology and Head and Neck Surgery, Saint Anne's University Hospital and Faculty of Medicine, Masaryk University Brno, Czech Republic

    1 shared publication
  • Bretislav Gal

    Department of Otorhinolaryngology and Head and Neck Surgery, St. Anne’s University Hospital in Brno

    1 shared publication
  • Ermis Vogazianos

    Dorset County Hospital NHS Foundation Trust, Dorchester, United Kingdom

    1 shared publication
  • Jiri Vanicek

    Department of Imaging Methods, Saint Anne's University Hospital and Faculty of Medicine, Masaryk University Brno, Czech Republic

    1 shared publication
  • Markéta Hudečková

    Department of Otorhinolaryngology and Head and Neck Surgery, Faculty of Medicine, Masaryk University and St. Anne’s University Hospital, 65691 Brno, Czech Republic

    1 shared publication
  • Marta Pazourkova

    Department of Imaging Methods, Saint Anne's University Hospital and Faculty of Medicine, Masaryk University Brno, Czech Republic

    1 shared publication

Latest Publications

  • Open Access

    Gene Mutations in Circulating Tumour DNA as a Diagnostic and Prognostic Marker in Head and Neck Cancer—A Systematic Review

    by Markéta Hudečková, Vladimír Koucký, Jan Rottenberg, Břetislav Gál

    (1) Background: Head and Neck Squamous Cell Carcinoma (HNSCC) is one of the most common malignancies globally. An early diagnosis of this disease is crucial, and the detection of gene mutations in circulating tumour DNA (ctDNA) through a liquid biopsy is a promising non-invasive diagnostic method. This review aims to provide an overview of ctDNA mutations in HNSCC patients and discuss the potential use of this tool in diagnosis and prognosis. (2) Methods: A systematic search for articles published in the English language between January 2000 and April 2021 in the Medline and Scopus databases was conducted. (3) Results: A total of 10 studies published in nine publications were selected and analysed. Altogether, 390 samples were obtained from HNSCC patients, and 79 control samples were evaluated. The most often explored gene mutation in ctDNA was TP53. (4) Conclusions: The examination of a larger group of gene mutations and the use of a combination of multiple detection methods contribute to a higher detection rate of mutated ctDNA. More studies are necessary to verify these conclusions and to translate them into clinical practice.


  • Open Access

    Diagnosis of retrocochlear lesions with emphasis on expansion of the cerebellopontine angle

    by Bretislav Gal, Jan Rottenberg, Marta Pazourkova, Jiri Vanicek, Ermis Vogazianos

    The correct diagnosis of CPA tumours is a relatively common issue in both neurological and ENT practice, the omission of which can have serious consequences for the patient. Properly set clinical guidelines and diagnostic protocols are key aspects of good clinical practice. In the case of CPA tumours, two options are available: the first is diagnosis with the help of an ABR as the primary tool for determining the group of patients with a possible tumour; the second is an MRI scan of the posterior cranial fossa. With an appropriately set diagnostic protocol in place, and despite the 40% chance of failure of the ABR to detect tumours less than or equal to 1 cm, similar treatment results can be achieved with much higher cost efficacy in case of primary ABR testing.